Norges Bank’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Norges Bank’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-102,506	Closed	-$6.13M	–	2179
2020 Q2	$6.13M	Buy	102,506 +78,709	+331%	+$4.86M	﹤0.01%	1833
2020 Q1	$1.41M	Buy	23,797 +8,028	+51%	+$468K	﹤0.01%	1955
2019 Q4	$864K	Buy	+15,769	New	+$589K	﹤0.01%	2031
2018 Q4	–	Sell	-15,000	Closed	-$438K	–	2145
2018 Q3	$438K	Buy	+15,000	New	+$423K	﹤0.01%	2101

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Norges Bank's PRNB Position: Q3 2020 in Review

Norges Bank sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 102,506 shares — an estimated $6.13M sold.

Norges Bank first reported a position in PRNB in Q3 2018 and held it in 4 quarters. The position peaked at $6.13M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Norges Bank reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Norges Bank sold 102,506 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $6.13M.
Norges Bank first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 4 quarters.
Norges Bank's Principia Biopharma Inc. Common Stock position peaked at $6.13M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Norges Bank's 13F filing for Q3 2020, filed 10 Nov 2020.